Pfizer (PFE)
(Delayed Data from NYSE)
$28.01 USD
-0.17 (-0.60%)
Updated May 10, 2024 04:00 PM ET
After-Market: $28.01 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Earnings News For PFE
-
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
-
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
-
Pfizer: Q1 Earnings Snapshot
-
Pfizer Reports First-Quarter 2024 Results
-
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
-
Pfizer (PFE) Down 0.2% Since Last Earnings Report: Can It Rebound?
-
Pfizer (PFE) Q4 Earnings Top, Revenues Miss on COVID Sales Slump
-
Pfizer: Q4 Earnings Snapshot
-
Pfizer (PFE) Surpasses Q4 Earnings Estimates
-
Will New Drugs Drive Pfizer (PFE) Sales in Q4 Earnings?
-
Pfizer (PFE) to Report Q4 Earnings: Here's What to Expect
-
Earnings Preview: Pfizer (PFE) Q4 Earnings Expected to Decline
-
Why Is Pfizer (PFE) Down 1.4% Since Last Earnings Report?
-
Pfizer (PFE) Reports Q3 Loss, Lags Revenue Estimates
-
Pfizer: Q3 Earnings Snapshot
-
Pfizer Reports Third-Quarter 2023 Results
-
Pfizer's (PFE) Key Drugs to Drive Q3 Earnings Amid COVID Decline?
-
Earnings Preview: Pfizer (PFE) Q3 Earnings Expected to Decline
-
Pfizer (PFE) to Report Q3 Earnings: Here's What to Expect
-
Why Is Pfizer (PFE) Up 1.6% Since Last Earnings Report?
-
Pfizer's (PFE) Q2 Earnings Beat, Sales Miss, Stock Declines
-
Pfizer (PFE) Surpasses Q2 Earnings Estimates
-
Pfizer: Q2 Earnings Snapshot
-
Pfizer Reports Second-Quarter 2023 Results
-
How Will Pfizer's (PFE) Key Drugs Perform in Q2 Earnings?